A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
연구 개요
This study is researching an experimental drug called mibavademab (also called "study drug"). The study is focused on patients with a condition called Functional Hypothalamic Amenorrhea (FHA). FHA is a condition where a woman stops menstruating because the brain is not sending the correct hormonal signals to the ovaries, which then are not able to cycle and ovulate properly. The aim of the study is to see how well the study drug helps the body make the hormones necessary for ovulation and reproduction, and to assess its safety. The study is looking at several other research questions, including: * Whether the drug helps bone health * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
- 스폰서
- 리드: 리제네론
- 적응증
- Functional Hypothalamic Amenorrhea (FHA)
- 중재
- Mibavademab, Placebo
- 목표 등록
- 34명
- 시작일
- 2026-03-11
- 완료(예정)
- 2027-12-08
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.